Fact CheckerSign in

NCT07325604Recruiting

Effect of Neuromuscular Electrical Stimulation on Unilateral Central Facial Palsy

Effect of Neuromuscular Electrical Stimulation on Unilaterial Central Facial Palsy: An Assesorblinded Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 9 Mar 2026

Brief summary (registry, in English)

Background Central facial palsy (CFP) is a common condition in stroke, with an estimated prevalence of 45%. CFP can lead to facial asymmetry, problems with mouth closure and food processing, bite marks on the cheek, social isolation, and reduced quality of life. CFP is seen as an important area of rehabilitation, and training is therefore often carried out to reduce the consequences of CFP. In a recent systematic review conducted by the principal investigator, the results showed that very few studies have been conducted that have investigated the effect of training for CFP, and there is currently no scientific evidence to support the effect of the various training interventions. Objective To investigate the effect of Neuromuscular electrical stimulation (NMES) on facial symmetry compared to usual practice, in participants with CFP as a result of stroke. Hypothesis: Participants who receive training with NMES together with usual training for facial paralysis have greater improvement in facial symmetry than participants who only receive usual training for facial paralysis. Trial design Randomized controlled trial (RCT) with a nested pilot trial. A pilot trial/RCT will be conducted in order to power calculation in an RCT. The protocol for the pilot trial and RCT will be the same, and participants from the pilot trial and their outcome data are thus expected to be included in the RCT.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
130 (estimated)
First submitted
7 Jan 2026
Start date
27 Feb 2026
Primary completion date
15 Dec 2030
Lead sponsor
University of Aarhus
Diseases
Stroke
NCT number
NCT07325604

What you commit to

  • Study type: Interventional
  • Planned participants: 130
  • From 27 Feb 2026 to the primary completion date, 15 Dec 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Not able to cooperate for mimical exercises
  • Contraindications for NMES
  • Admitted for three weeks assessment stay at the hospital

Who the study is looking for

  • Central facial palsy
  • First time stroke
  • \>=18 years
  • Able to provide written consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hammel neurorehabilitation centre and university research clinic
Coordinator of this site? Confirm its status
HammelDenmarkRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.